Clomipramine * Generic, Anafranil
Desipramine Generic, Norpramin
Doxepin Generic, Sinequan
Imipramine Generic, Tofranil
Nortriptyline Generic, Pamelor
Protriptyline Generic, Vivactil
Bupropion Generic, Wellbutrin
Mirtazapine Generic, Remeron
Phenelzine Generic, Nardil
Selegiline Generic, Eldepryl
Tranylcypromine Generic, Parnate *Labeled only for obsessive-compulsive disorder.
†Labeled only for fibromyalgia.
Aan Het Rot M et al: Ketamine for depression: Where do we go from here? Biol Psychiatry 2012;72:537.
Alam MY et al: Safety, tolerability, and efficacy of vortioxetine (Lu AA21004) in major depressive disorder: Results of an open-label, flexible-dose, 52-week extension study. Int Clin Psychopharmacol 2014;29:39.
Alessandro S, Kato M: The serotonin transporter gene and effectiveness of SSRIs. Expert Rev Neurother 2008;8(1):111.
Bab I, Yirmiya R: Depression, selective serotonin reuptake inhibitors, and osteoporosis. Curr Osteoporos Rep 2010;8:185.
Barrera AZ, Torres LD, Munoz RF: Prevention of depression: The state of the science at the beginning of the 21st century. Int Rev Psychiatry 2007;19:655.
Bellingham GA, Peng PW: Duloxetine: A review of its pharmacology and use in chronic pain management. Reg Anesth Pain Med 2010;35:294.
Belmaker R, Agam G: Major depressive disorder. N Engl J Med 2008;358:55.
Bockting CL et al: Continuation and maintenance use of antidepressants in recurrent depression. Psychother Psychosom 2008;77:17.
Bonisch H, Bruss M: The norepinephrine transporter in physiology and disease. Handb Exp Pharmacol 2006;175:485.
Castren E, Voikar V, Rantamaki T: Role of neurotrophic factors in depression. Curr Opin Pharmacol 2007;7:18.
Chaki S et al: mGlu2/3 and mGlu5 receptors: Potential targets for novel antidepressants. Neuropharmacology 2013;66:40.
Chappell AS et al: A double-blind, randomized, placebo-controlled study of the efficacy and safety of duloxetine for the treatment of chronic pain due to osteoarthritis of the knee. Pain Pract 2011;11:33.
Chen G et al: Pharmacokinetic drug interactions involving vortioxetine (Lu AA21004), a multimodal antidepressant. Clin Drug Investig 2013;33:727.
Cipriani A et al: Fluoxetine versus other types of pharmacotherapy for depression. Cochrane Database Syst Rev 2005;4:CD004185.
Cipriani A et al: Metareview on short-term effectiveness and safety of antidepressants for depression: An evidence-based approach to inform clinical practice. Can J Psychiatry 2007;52:553.
Citrome L: Vortioxetine for major depressive disorder: A systematic review of the efficacy and safety profile for this newly approved antidepressant—What is the number needed to treat, number needed to harm and likelihood to be helped or harmed? Int J Clin Pract 2014;68:60.